Bioequivalence of Nilotinib 200 mg Capsules in Healthy Participants Under Fasting Conditions.
BLCL-NIL-FDA-02
Phase 1 other active
Quick answer
Bioequivalence of Nilotinib 200 mg Capsules in Healthy Participants Under Fasting Conditions. for No medical condition. is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- No medical condition.
- Phase
- Phase 1
- Modality
- other
- Status
- active